Developer docs
API playgroundTry for free, no card

Search company profiles

Atom

Full company profile

uuid00023cx

Namestring
Atom
Legal namestring
Atom
Websiteurl
atombodies.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Atom is a San Francisco-based hardware company developing AI-powered prosthetic limbs, anchored by its flagship product the Atom Touch artificial arm and the proprietary Atom A1 neural interface. The system reads neuromuscular biosignals non-invasively from the residual limb and uses AI to drive individual finger, wrist, and elbow control, with dozens of touch sensors and over 10 motors in the hand providing haptic feedback and dexterity. The company targets the approximately 100 million people globally with limb loss or congenital difference — a population that Atom cites as having less than 1% prosthetics adoption due to capability and cost limitations of existing solutions.

Atom operates a direct-to-consumer go-to-market through a multi-step qualified-applicant waitlist and preview program at atombodies.com, with Atom Touch currently available for pre-order to preview participants ahead of general availability. Revenue is intended to come from one-time hardware sales of the prosthetic device; pricing is not publicly disclosed and no unit revenue has been reported. The company also frames its long-term mission around 'artificial bodies' spanning multiple body systems, of which the arm is the first product.

The company was founded in 2020 by Tyler Hayes (CEO, prior co-founder/COO of Bebo and employee #10 at Disqus), Doug Satzger (Chief Design Officer, ex-Apple design lead under Steve Jobs, with 500+ patents), and Eric Monsef (CTO, ex-Apple Core Hardware Team architect, 40+ patents). Medical Director Jayant Menon, MD, joined from Neuralink, where he was original first author of the First-in-Human FDA Early Feasibility trial. To date, Atom has disclosed approximately $7.7M in capital raised across multiple rounds, including a $5.5M April 2022 round led with J4.Ventures and Moai Capital, a $4M Wefunder crowdfunding raise, a $2M 2021 round with Bay Wharf Capital and Meyer Global, an NSF grant, and a Village Global founding investment.

Short descriptiontext

Atom is a San Francisco hardware company building the Atom Touch, an AI-powered prosthetic arm driven by its proprietary Atom A1 neural interface for individual finger control and haptic feedback. It targets the 100 million people globally with limb loss and sells through a direct-to-consumer waitlist and pre-order program.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
AI-powered prosthetics, neural interface limbs, artificial arm devices, wearable robotics, haptic prosthetic feedback
Industry2 codes
PRIMARYHDACAFAL
Assistive & Accessibility Input Devices (Switches, Adaptive Controllers, Braille Keyboards)
Hardware, Technology & Telecom/Computing Hardware & Peripherals/Input Devices & Accessories (Keyboards, Mice, Controllers)
SECONDARYHDAAAIAL
Robot Hardware, Actuators & Components (sensors, grippers, motors)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Prosthetic Devices
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Hardware Sales - Atom Touch
TypeHardware Sales
Description

Atom generates revenue from the sale of the Atom Touch artificial arm. The product is available for pre-order to preview participants before public availability. Revenue is generated through one-time hardware sales of the prosthetic device.

atombodies.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Atom Touch
Description

The first commercially-viable artificial arm featuring AI neural interface (Atom A1), individual finger control, load-balanced harness attachment, touch sensors with haptics, and over 10 motors in the hand for dexterity.

atombodies.com
Core offering1 text field

Atom designs and sells the Atom Touch, an AI-powered artificial arm with individual finger control, powered by the Atom A1 non-invasive neural interface that trains in minutes. The product combines dozens of touch sensors with haptic feedback, over 10 motors in the hand, and a load-balanced harness that is lighter than a human arm. It is targeted at individuals with limb loss or congenital difference and is sold direct-to-consumer via a waitlist and pre-order program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Near-full human range of motion achieved
+3 more records
Product overview1 text field

Atom offers a unified artificial limb product portfolio centered on the Atom Touch prosthetic arm, which is powered by the proprietary Atom A1 neural interface. The Atom Touch represents the first commercially-viable artificial arm with AI-driven mind control, individual finger dexterity, and haptic touch feedback. The system enables users with limb loss or congenital difference to achieve near-full human range of motion through intuitive neural interface training, targeting the 100 million people worldwide who could benefit from advanced prosthetics.

Product and service2 records
1Atom Touch
CategoryProsthetic Devices
Description

The first commercially-viable artificial arm, featuring individual finger control, dozens of touch sensors with haptic feedback, over 10 motors in the hand, and a load-balanced harness that distributes weight across the torso. It is powered by the Atom A1 AI neural interface and is designed for individuals with upper-limb loss or congenital limb difference seeking near-full human range of motion.

2Atom A1
CategoryNeural Interface Technology
Description

The first AI neural interface for artificial limbs, designed as a non-invasive biosensor that slides onto the residual limb to read neuromuscular signals. It enables intuitive, natural control of prosthetic elbow, wrist, and fingers, with training achievable in minutes, and serves as the control system for the Atom Touch arm.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Psyonic makes the Ability Hand, an advanced bionic prosthetic hand with touch-sensor feedback and multi-articulating finger control for upper-limb amputees — directly comparable to Atom Touch on product category, target user, and sensory-feedback differentiation.

TypeDirect peer
Description

Open Bionics builds multi-grip bionic arms (Hero Arm) with individual finger control for below-elbow amputees, competing in the same commercial upper-limb prosthetic segment with a direct-to-consumer-leaning model.

TypeDirect peer
Description

Esper Bionics produces a self-learning bionic hand with EMG-based control and cloud updates for upper-limb amputees, comparable to Atom Touch in AI-driven control and direct-to-patient positioning.

4DEKA / Mobius Bionics
TypeDirect peer
Description

DEKA developed the LUKE Arm (commercialized via Mobius Bionics), a mind-controlled multi-articulating prosthetic arm with shoulder, elbow, wrist, and hand control — the closest large-scale, FDA-cleared comparable to Atom Touch's feature set.

TypeBroad incumbent
Description

Ottobock is the world's largest prosthetics manufacturer with a broad upper- and lower-limb portfolio, established reimbursement infrastructure, and a global prosthetist network — the dominant incumbent Atom must displace or partner with.

TypeBroad incumbent
Description

Ossur (parent of Touch Bionics / i-Limb) is a global orthopedic and prosthetics leader with extensive clinical distribution, competing across both upper- and lower-limb segments where Atom could expand.

TypeEmerging player
Description

BrainCo develops brain-computer interfaces and a bionic prosthetic hand with EMG control, an emerging direct competitor in AI-driven upper-limb prosthetics with overlapping neural-interface technology.

8Sarcos Robotics
TypeOthers
Description

Sarcos develops wearable robotic exoskeletons for industrial and military strength augmentation, adjacent to Atom's wearable-robotics roadmap and overlapping in defense/customer use cases.

TypeOthers
Description

Ekso Bionics builds robotic exoskeletons for medical rehabilitation and mobility impairment, comparable to Atom's longer-term lower-limb and human-augmentation roadmap.

TypeOthers
Description

Neuralink develops implantable brain-computer interfaces; while not a prosthetic-limb competitor, it is a related neural-interface platform and shares Atom's Medical Director (Jayant Menon) as a former Neuralink clinical lead.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Atom

Prosthetic Devicesatombodies.com

Atom is a San Francisco hardware company building the Atom Touch, an AI-powered prosthetic arm driven by its proprietary Atom A1 neural interface for individual finger control and haptic feedback. It targets the 100 million people globally with limb loss and sells through a direct-to-consumer waitlist and pre-order program.

What Atom does

Atom is a San Francisco-based hardware company developing AI-powered prosthetic limbs, anchored by its flagship product the Atom Touch artificial arm and the proprietary Atom A1 neural interface. The system reads neuromuscular biosignals non-invasively from the residual limb and uses AI to drive individual finger, wrist, and elbow control, with dozens of touch sensors and over 10 motors in the hand providing haptic feedback and dexterity. The company targets the approximately 100 million people globally with limb loss or congenital difference — a population that Atom cites as having less than 1% prosthetics adoption due to capability and cost limitations of existing solutions.

Atom operates a direct-to-consumer go-to-market through a multi-step qualified-applicant waitlist and preview program at atombodies.com, with Atom Touch currently available for pre-order to preview participants ahead of general availability. Revenue is intended to come from one-time hardware sales of the prosthetic device; pricing is not publicly disclosed and no unit revenue has been reported. The company also frames its long-term mission around 'artificial bodies' spanning multiple body systems, of which the arm is the first product.

The company was founded in 2020 by Tyler Hayes (CEO, prior co-founder/COO of Bebo and employee #10 at Disqus), Doug Satzger (Chief Design Officer, ex-Apple design lead under Steve Jobs, with 500+ patents), and Eric Monsef (CTO, ex-Apple Core Hardware Team architect, 40+ patents). Medical Director Jayant Menon, MD, joined from Neuralink, where he was original first author of the First-in-Human FDA Early Feasibility trial. To date, Atom has disclosed approximately $7.7M in capital raised across multiple rounds, including a $5.5M April 2022 round led with J4.Ventures and Moai Capital, a $4M Wefunder crowdfunding raise, a $2M 2021 round with Bay Wharf Capital and Meyer Global, an NSF grant, and a Village Global founding investment.

Atom firmographics

Firmographics
Name
Atom
Legal name
Atom
Website
https://atombodies.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Atom is a San Francisco hardware company building the Atom Touch, an AI-powered prosthetic arm driven by its proprietary Atom A1 neural interface for individual finger control and haptic feedback. It targets the 100 million people globally with limb loss and sells through a direct-to-consumer waitlist and pre-order program.
Ownership category
akta.pro rank

Atom industry classification

Industry
Product category
Prosthetic Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHDACAFAL
Assistive & Accessibility Input Devices (Switches, Adaptive Controllers, Braille Keyboards)
Hardware, Technology & Telecom/Computing Hardware & Peripherals/Input Devices & Accessories (Keyboards, Mice, Controllers)
SECONDARYHDAAAIAL
Robot Hardware, Actuators & Components (sensors, grippers, motors)

Keywords

  • AI-powered prosthetics
  • Neural interface limbs
  • Artificial arm devices
  • Wearable robotics
  • Haptic prosthetic feedback

Where Atom is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Markets served

Atom business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Hardware Sales - Atom Touch: Atom generates revenue from the sale of the Atom Touch artificial arm. The product is available for pre-order to preview participants before public availability. Revenue is generated through one-time hardware sales of the prosthetic device.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Atom product offering

Product offering

Core offering

Atom designs and sells the Atom Touch, an AI-powered artificial arm with individual finger control, powered by the Atom A1 non-invasive neural interface that trains in minutes. The product combines dozens of touch sensors with haptic feedback, over 10 motors in the hand, and a load-balanced harness that is lighter than a human arm. It is targeted at individuals with limb loss or congenital difference and is sold direct-to-consumer via a waitlist and pre-order program.

Product overview

Atom offers a unified artificial limb product portfolio centered on the Atom Touch prosthetic arm, which is powered by the proprietary Atom A1 neural interface. The Atom Touch represents the first commercially-viable artificial arm with AI-driven mind control, individual finger dexterity, and haptic touch feedback. The system enables users with limb loss or congenital difference to achieve near-full human range of motion through intuitive neural interface training, targeting the 100 million people worldwide who could benefit from advanced prosthetics.

Differentiator

Problem solved

Functional benefit

Brands

  • Atom Touch: The first commercially-viable artificial arm featuring AI neural interface (Atom A1), individual finger control, load-balanced harness attachment, touch sensors with haptics, and over 10 motors in the hand for dexterity.

Products and services

  • Atom Touch The first commercially-viable artificial arm, featuring individual finger control, dozens of touch sensors with haptic feedback, over 10 motors in the hand, and a load-balanced harness that distributes weight across the torso. It is powered by the Atom A1 AI neural interface and is designed for individuals with upper-limb loss or congenital limb difference seeking near-full human range of motion.
  • Atom A1 The first AI neural interface for artificial limbs, designed as a non-invasive biosensor that slides onto the residual limb to read neuromuscular signals. It enables intuitive, natural control of prosthetic elbow, wrist, and fingers, with training achievable in minutes, and serves as the control system for the Atom Touch arm.

Quantifiable outcome

  • Near-full human range of motion achieved
  • +3 more outcomes

Companies that use Atom

Customer profile

Segments1 record

Ideal customer profiles1 record

Atom technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Atom partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Atom competitors and assessment

Company assessment

Direct peers

  • Psyonic: Psyonic makes the Ability Hand, an advanced bionic prosthetic hand with touch-sensor feedback and multi-articulating finger control for upper-limb amputees — directly comparable to Atom Touch on product category, target user, and sensory-feedback differentiation.
  • Open Bionics: Open Bionics builds multi-grip bionic arms (Hero Arm) with individual finger control for below-elbow amputees, competing in the same commercial upper-limb prosthetic segment with a direct-to-consumer-leaning model.
  • Esper Bionics: Esper Bionics produces a self-learning bionic hand with EMG-based control and cloud updates for upper-limb amputees, comparable to Atom Touch in AI-driven control and direct-to-patient positioning.
  • DEKA / Mobius Bionics: DEKA developed the LUKE Arm (commercialized via Mobius Bionics), a mind-controlled multi-articulating prosthetic arm with shoulder, elbow, wrist, and hand control — the closest large-scale, FDA-cleared comparable to Atom Touch's feature set.

Broad incumbents

  • Ottobock: Ottobock is the world's largest prosthetics manufacturer with a broad upper- and lower-limb portfolio, established reimbursement infrastructure, and a global prosthetist network — the dominant incumbent Atom must displace or partner with.
  • Ossur: Ossur (parent of Touch Bionics / i-Limb) is a global orthopedic and prosthetics leader with extensive clinical distribution, competing across both upper- and lower-limb segments where Atom could expand.

Emerging players

  • BrainCo: BrainCo develops brain-computer interfaces and a bionic prosthetic hand with EMG control, an emerging direct competitor in AI-driven upper-limb prosthetics with overlapping neural-interface technology.

Others

  • Sarcos Robotics: Sarcos develops wearable robotic exoskeletons for industrial and military strength augmentation, adjacent to Atom's wearable-robotics roadmap and overlapping in defense/customer use cases.
  • Ekso Bionics: Ekso Bionics builds robotic exoskeletons for medical rehabilitation and mobility impairment, comparable to Atom's longer-term lower-limb and human-augmentation roadmap.
  • Neuralink: Neuralink develops implantable brain-computer interfaces; while not a prosthetic-limb competitor, it is a related neural-interface platform and shares Atom's Medical Director (Jayant Menon) as a former Neuralink clinical lead.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Atom social profiles

Digital presence

Atom financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Atom leadership team

Management profile

Number of profiles

Profiles4 records

Atom funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Atom M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atom

What does Atom do?

Atom designs and sells the Atom Touch, an AI-powered artificial arm with individual finger control, powered by the Atom A1 non-invasive neural interface that trains in minutes. The product combines dozens of touch sensors with haptic feedback, over 10 motors in the hand, and a load-balanced harness that is lighter than a human arm. It is targeted at individuals with limb loss or congenital difference and is sold direct-to-consumer via a waitlist and pre-order program.

Is Atom a public or private company?

Atom is a private company. It is classified as venture growth investor backed and is currently operating.

When was Atom founded?

Atom was founded in 2020. It employs 11 to 50 people.

Where is Atom based?

Atom is headquartered in San Francisco, United States, in the North America region.

How does Atom make money?

One revenue line is on record: hardware Sales - Atom Touch.

Who are Atom's main competitors?

Direct peers on record are Psyonic, Open Bionics, Esper Bionics and DEKA / Mobius Bionics. Broad incumbents are Ottobock and Ossur. BrainCo is listed as an emerging player. Others are Sarcos Robotics, Ekso Bionics and Neuralink.

Does Atom have an API?

No public API is recorded for Atom.

What industry is Atom in?

Atom's product category is Prosthetic Devices. Its primary akta.pro industry code is HDACAFAL, Assistive & Accessibility Input Devices (Switches, Adaptive Controllers, Braille Keyboards), with a secondary code of HDAAAIAL, Robot Hardware, Actuators & Components (sensors, grippers, motors). Its NAICS code is 334510 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BBCThe 'mind-bending' bionic arm powered by AIA company in California, Atom Limbs, has developed a next-generation, AI-powered bionic arm that interprets electrical signals from the brain to control the limb, which includes sensors, machine learning, and haptic feedback. The prosthetic is non-invasive, offers full range of motion, and is expected to cost around $20,000, making it more affordable compared to other bionic devices.Business Wire BlogRetail Investors Rally Behind Robotics Startup Atom Limbs, Raising Millions for World’s First Artificial Human ArmAtom Limbs raised over $7M from retail investors on Wefunder for its artificial human arm. The company has a waitlist of over 9,000 buyers and forecasts $180M+ in revenue, targeting the $800B+ physical disability industry.BenzingaThis Startup Is Creating The World's First Mind-Controlled Prosthetic Arm - Last Call To Invest - Apple (Atom Limbs, a Silicon Valley-based startup, has raised over $3.5 million from more than 2,400 retail investors through equity crowdfunding on Wefunder to develop the world's first mind-controlled prosthetic arm. The company's technology, developed under an exclusive agreement with Johns Hopkins to commercialize its DARPA-funded Modular Prosthetic Limb, offers near-human range of motion, restored touch sensation, and individually dexterous fingers controllable by thought. The startup aims to address the $800 billion physical disability market, where currently only 20% of 65 million amputees use prosthetics due to pain, limited functionality, and prohibitive costs.CrowdFund InsiderAtom Limbs Raises Over $1 Million in Under One Hour on WefunderAtom Limbs raised over $1 million in under an hour on Wefunder, with the offering now exceeding $2 million from over 1,200 investors. The company, co-founded by Tyler Hays, uses a SAFE with a $40 million valuation cap and aims to launch its artificial arm globally in 2023.